approval · primary record
DOSTARLIMAB-GXLY
FDA · BLA · 2026-10-19
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-19 |
| Brand | JEMPERLI |
| Sponsor | GLAXOSMITHKLINE |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:04.616Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DOSTARLIMAB-GXLY:2026-10-19
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.